Urinary Concentrations of Phthalate Metabolites in Relation to Pregnancy Loss among Women Conceiving with Medically Assisted Reproduction
Supporting Files
-
11 2016
-
File Language:
English
Details
-
Alternative Title:Epidemiology
-
Personal Author:
-
Corporate Authors:
-
Description:Background
Animal studies demonstrate that several phthalates are embryofetotoxic and are associated with increased pregnancy loss and malformations. Results from human studies on phthalates and pregnancy loss are inconsistent.
Methods
We examined pregnancy loss prospectively in relation to urinary phthalate metabolite concentrations among women undergoing medically assisted reproduction. We used data from 256 women conceiving 303 pregnancies recruited between 2004 and 2012 from the Massachusetts General Hospital Fertility Center. We quantified eleven phthalate metabolite concentrations and calculated the molar sum of four di(2-ethylhexyl) phthalate (DEHP) metabolites (ΣDEHP). We estimated risk ratios (RRs) and 95% confidence intervals (CIs) for biochemical loss and total pregnancy loss (<20 weeks’ gestation) across quartiles using repeated measures log-binomial models, adjusted for age, body mass index, smoking and infertility diagnosis.
Results
Of the 303 pregnancies, 83 (27%) ended in loss less than 20 weeks’ gestation and among these, 31 (10%) ended in biochemical loss. Although imprecise, the RRs for biochemical loss increased across quartiles of ∑DEHP and three individual DEHP metabolites. For ∑DEHP, the RRs (CIs) were: 2.3 (0.63, 8.5), 2.0 (0.58, 7.2), and 3.4 (0.97, 11.7) for quartiles two, three and four, compared to one, respectively (p-trend=0.04). RRs for total pregnancy loss were elevated in the highest quartiles of ΣDEHP and three DEHP metabolites. The remaining seven phthalate metabolite concentrations evaluated were not associated with either outcome.
Conclusions
We found a suggestive pattern of association between conception cycle-specific urinary concentrations of DEHP metabolites and biochemical and total pregnancy loss among women undergoing medically assisted reproduction.
-
Subjects:
-
Source:Epidemiology. 27(6):879-888
-
Pubmed ID:27299194
-
Pubmed Central ID:PMC5248552
-
Document Type:
-
Funding:P30 ES000002/ES/NIEHS NIH HHSUnited States/ ; K23 ES021471/ES/NIEHS NIH HHSUnited States/ ; R01 ES009718/ES/NIEHS NIH HHSUnited States/ ; CIHRCanada/ ; CC999999/Intramural CDC HHSUnited States/ ; T32 ES007069/ES/NIEHS NIH HHSUnited States/ ; T32 DK007703/DK/NIDDK NIH HHSUnited States/ ; R01 ES022955/ES/NIEHS NIH HHSUnited States/
-
Place as Subject:
-
Volume:27
-
Issue:6
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c2956f8b1cff65ee2e95ca4340364e101ad99befd8e8c511253eb126aa2474bc8f57d34fc3419d8ae2c3b87ce86c5930847c873d9b441724d10c439014adeb4c
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access